Results 41 to 50 of about 3,182,211 (266)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR [PDF]

, 2019
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who ...
Berenguer, Juan, Carrero, Ana, Crespo, Manuel, González García, Juan, Guardional, Josep M., Gómez, Julián, Jiménez Sousa, María Angeles, Martínez, Isidoro, Resino, Salvador, Santos, Ignacio de los, The GESIDA 3603b Cohort Study Group, Vigón, Lorena, Von Wichmann, Miguel A., Vázquez Morón, Sonia, Yélamos, María Belén   +14 more
core   +4 more sources

MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3.

Virology, 2014
MiR-221 was reported to be upregulated and play roles in tumorigenesis of hepatitis C virus (HCV) associated hepatocellular carcinoma (HCC). However, the role of miR-221 in HCV infection remains unknown.
Gang Xu, Fang Yang, Cuiling Ding, Jing Wang, P. Zhao, Wen Wang, H. Ren   +6 more
semanticscholar   +1 more source

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients [PDF]

Türk Biyokimya Dergisi, 2007
Hepatitis C Virus (HCV) infection is frequently diagnosed by detection of antibodyagainst the HCV (Anti-HCV). The seropositivity of anti-HCV could reflect chronicinfectious status and/or previous infection.
Tuğrul Himmetoğlu, Hüseyin Şimşek, Aygül Türkmen, Doğan Cengiz, Gülsevim Saydam, Mevhibe Balk   +5 more
doaj  

The prevalence of hepatitis C virus among people of South Asian origin in Glasgow: results from a community based survey and laboratory surveillance [PDF]

, 2013
Background South Asians often present late with HCV or HBV related liver disease which could have been avoided with early diagnosis and subsequent treatment; however the prevalence of HCV/HBV among South Asians in Glasgow is not known.
Ahmed, S., Anderson, Eleanor, Banday, Shabir, Cameron, Sheila, Foster, Graham R., Fox, Ray, Goldberg, David, Hutchinson, Sharon J., McLeod, Allan, McTaggart, Christine, Mills, Peter R., O'Leary, Maureen C., Sarwar, Mohammed, Schofield, Joe, Weir, Amanda   +14 more
core   +2 more sources

Hepatitis C testing and status among opioid substitution treatment clients in New South Wales

Australian and New Zealand Journal of Public Health, 2014
Background: In Australia about half of the people who inject drugs (PWID) are hepatitis C (HCV) antibody positive (anti‐HCV+). The prevalence among opioid substitution treatment (OST) clients specifically is unclear, despite OST clinics being a potential
Fiona L. Shand, Carolyn Day, William Rawlinson, Louisa Degenhardt, Nicholas G. Martin, Elliot C. Nelson   +5 more
doaj   +1 more source

Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs. [PDF]

PLoS ONE, 2014
OBJECTIVES: To assess HCV viremia levels just before, during and one year after anti-HCV seroconversion in people who inject drugs (PWID). METHODS: PWID enrolling into a needle exchange program in Malmö, Sweden, 1997-2005 constituted the source ...
Marianne Alanko Blomé, Per Björkman, Vilma Molnegren, Peter Höglund, Anders Widell   +4 more
doaj   +1 more source

HCV-RNA and Anti-HCV IgM in Egyptian Subjects Bearing IgG Anti-HCV Antibodies

Japanese Journal of Infectious Diseases, 1999
The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy ...
A, el-Gohary, A M, Hosny, N, Fawaz, A, Heiba, E, Abdalla, F, Kawano, T, Kiyokawa   +6 more
openaire   +3 more sources

Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups

Kaohsiung Journal of Medical Sciences, 2011
We evaluated the performance of a hepatitis C virus (HCV) antigen/antibody combination test [Murex HCV Antigen/Antibody Combination Test (Murex Ag/Ab test)] by comparing it with the current third-generation HCV antibody enzyme immunoassay (anti-HCV).
Jeng-Fu Yang, Ya-Yun Lin, Meng-Hsuan Hsieh, Chiu-Hung Tsai, Shu-Fen Liu, Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Wen-Yi Lin, Zu-Yau Lin, Shinn-Chern Chen, Wan-Long Chuang   +11 more
doaj   +1 more source

Community screening for hepatitis C virus infection in a low-prevalence population

BMC Public Health, 2019
Background Age cohort screening for hepatitis C virus (HCV) might be an effective strategy if the majority of undiagnosed cases are concentrated in a particular age group.
Karen K. Kyuregyan, Elena Yu. Malinnikova, Natalia V. Soboleva, Olga V. Isaeva, Anastasia A. Karlsen, Vera S. Kichatova, Ilya A. Potemkin, Elena V. Schibrik, Olga A. Gadjieva, Boris A. Bashiryan, Natalya N. Lebedeva, Igor L. Serkov, Anna Yankina, Claudio Galli, Mikhail I. Mikhailov   +14 more
doaj   +1 more source

Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome [PDF]

, 2000
This study was undertaken to evaluate an enzyme immunoassay (EIA) for hepatitis C virus antibody detection (anti-HCV), using just one antigen. Anti-HCV EIA was designed to detect anti-HCV IgG using on the solid-phase a recombinant C22 antigen localized ...
Ferraz, Maria Lucia Cardoso Gomes, Granato, Celso Francisco Hernandes, Granero, L, Lanzoni, Valeria Pereira, Lopes, Epa, Paranhos-Baccala, G, Silva, Aeb, Tomiyama, H   +7 more
core   +4 more sources